References

Printer-friendly version

​We provide information that has been approved by healthcare professionals or has published evidence.

These are the references of the evidence used in the production of PAPAA information in scope under The Information Standard (TIS) scheme. The references reflect the evidence used when the material was last reviewed. If you believe that new evidence has emerged that may change the information we produce, please contact us.

The following are the leaflets we produce under TIS:

  • Clinical Trials: An overview
  • Emollients and Psoriasis
  • Genital Psoriasis
  • Nail Psoriasis
  • Occupational Therapy and Psoriatic Arthritis
  • Physiotherapy and Exercise: Psoriatic Arthritis
  • Psoriasis and Phototherapy
  • Psoriasis and sensitive areas
  • Psoriasis and the Heart
  • Psoriasis and the Sun
  • Psoriatic Arthritis: Did You Know?
  • Psoriatic arthritis: When to treat
  • Psoriatic Lifestyle and Nutrition
  • Psychological aspects of psoriasis
  • Pustular psoriasis
  • Scalp Psoriasis
  • The Psoriatic Foot
  • Treatments for Psoriasis: An overview
  • Treatment for Psoriatic Arthritis: An overview
  • What is Psoriasis?
  • What is Psoriatic Arthritis?

Clinical Trials: An overview
Last review: February 2016
Published: March 2016
Next review date: October 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008;35:1354-8.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.

Emollients and Psoriasis
Last review: June 2016
Published: June 2016
Next review: February 2019

References:

  • Parisi, R, Symmons, DPM, Griffiths, CEM & Ashcroft, DM 2013, 'Global epidemiology of psoriasis: A systematic review of incidence and prevalence' Journal of Investigative Dermatology, vol 133, no. 2, pp. 377-385., 10.1038/jid.2012.339
  • Parisi R, Griffiths CEM, Ashcroft DM (2011) Systematic review of the incidence and prevalence of psoriasis. British Journal of Dermatology 165: e5
  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
  • Schons KR, Beber AA, Beck Mde O, Monticielo OA.2015 Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features, An Bras Dermatol. 2015 May-Jun;90(3):314-9. doi: 10.1590/abd1806-4841.20153736. Epub 2015 Jun
  • Henes JC1, Ziupa E, Eisfelder M, Adamczyk A, Knaudt B, Jacobs F, Lux J, Schanz S, Fierlbeck G, Spira D, Horger M, Kanz L, Koetter I, High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study. Rheumatol Int. 2014 Feb;34(2):227-34. doi: 10.1007/s00296-013-2876-z. Epub 2013 Oct 10.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.
  • Psoriasis: The assessment and management of psoriasis. Issued: October 2012 NICE clinical guideline 153
  • Fluhr, J Cavallotti, C Berardesca, E (2008) Emollients, moisturizers and keratolytic agents in psoriasis Clin Dermatol 26:380-386
  • Tsang, M Guy, RH (2010) Effect of aqueous cream BP on stratum corneum in vivo. British Journal of Dermatology 163(5):954-58

Genital Psoriasis
Last review: September 2016
Published: October 2016
Next review : April 2019

References: 

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005; 141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on seronegative spondyloarthropathies. J Rheumatol 1999; 26:1752-6.
  • Meeuwis KA, de Hullu JA, Massuger LF, van de Kerkhof PC, van Rossum MM. Genital psoriasis: A systematic literature review on this hidden skin disease. Acta Derm Venereol. 2011 Jan; 91(1):5-11. doi: 10.2340/00015555-0988.
  • van de Kerkhof PC, Murphy GM, Austad J, Ljungberg A, Cambazard F, Duvold LB. Psoriasis of the face and flexures. J Dermatolog Treat. 2007; 18(6):351-60.
  • Mitchell T, Penzer R. Psoriasis at your fingertips 2nd ed. ISBN: 1-85959-117-5; Class Publishing (London Ltd) 2007; page 50.
  • The assessment and management of psoriasis. National Institute for Health and Care Excellence (NICE). NICE clinical guideline 153. October 2012.
  • Ryan C, Sadlier M, De Vol E et al Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J Am Acad Dermatol. 2015 Jun;72(6):978-83. doi: 10.1016/j.jaad.2015.02.1127. Epub 2015 Mar 29
  • Meeuwis KA, de Hullu JA, IntHout J, Hendriks IM, Sparreboom EE, Massuger LF, van de Kerkhof PC, van Rossum MM. Genital psoriasis awareness program: physical and psychological care for patients with genital psoriasis. Acta Derm Venereol. 2015 Feb;95(2):211-6. doi: 10.2340/00015555-1885.
  • J Molina-Leyva A, Almodovar-Real A, Ruiz-Carrascosa JC, Naranjo-Sintes R, Serrano-Ortega S, Jimenez-Moleon JJ. Distribution pattern of psoriasis affects sexual function in moderate to severe psoriasis: a prospective case series study.Sex Med. 2014 Dec;11(12):2882-9. doi: 10.1111/jsm.12710. Epub 2014 Sep 29. An Bras Dermatol. 2015 May-Jun;90(3):338-45. doi:
  • J Molina-Leyva A, Almodovar-Real A, Carrascosa JC, Molina-Leyva I, Naranjo-Sintes R, Jimenez-Moleon JJ.  Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis. 10.1590/abd1806-4841.20153254. Epub 2015 Jun 1.

Nail Psoriasis
Last review: August 2015.
Published: January 2016
Next review : May 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: A systematic review. J Rheumatol 2008;35:1354-8.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8. Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.

Occupational Therapy and Psoriatic Arthritis
Last review: June 2016.
Published: September 2016
Next review: November 2018

References:

  • Parisi, R, Symmons, DPM, Griffiths, CEM & Ashcroft, DM (2013). Global epidemiology of psoriasis: A systematic review of incidence and prevalence. Journal of Investigative Dermatology, vol 133, no. 2, pp. 377-385., 10.1038/jid.2012.339
  • Parisi R, Griffiths CEM, Ashcroft DM (2011). Systematic review of the incidence and prevalence of psoriasis. British Journal of Dermatology 165: e5
  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
  • Henes JC1, Ziupa E, Eisfelder M, Adamczyk A, Knaudt B, Jacobs F, Lux J, Schanz S, Fierlbeck G, Spira D, Horger M, Kanz L, Koetter I. High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study. Rheumatol  Int. 2014 Feb;34(2):227-34. doi: 10.1007/s00296-013-2876-z. Epub 2013 Oct 10.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Kay LJ, Parry-James JE, Walker DJ. The prevalence and impact of psoriasis and psoriatic arthritis in the primary care population in North East England. Arthritis Rheum 1999;42:S299.
  • Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis - An analysis of 220 patients. Q J Med 1987;62:127.
  • McHugh NJ, Balakrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis. Rheumatology 2003;42:778.

Physiotherapy and Exercise: Psoriatic Arthritis
Last review: May 2014
Published: May 2014
Next review: April 2016

References:

  • There is a large body of evidence for the benefits of exercise in inflammatory arthritis. It has usually been studied using rheumatoid arthritis (RA).
  • NICE guidelines 2009 state that exercise is beneficial for most individuals with RA.
  • Evidence for exact prescription, modes of exercise delivery and improving compliance with an exercise programme are limited. The current knowledge is summarised in:
  • Cooney JK et al. Benefits of Exercise in RA. Journal of aging research 2011; 1-14 (article ID 681640).
  • Hakkinen A et al. A randomised two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 2001; 44:515.

Psoriasis and Phototherapy
Last review: January 2016
Published: January 2016
Next review: June 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Anstey Alex, professor. Home UVB phototherapy for psoriasis: Editorials BMJ 2009;338:b607
  • Koek M, Buskens E, van Weelden H, Steegmans P, Bruijnzeel-Koomen C, Sigurdsson V. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis; pragmatic multicentre randomized controlled non-inferiority trial (PLUTO study) British Medical Journal 2009:338:b1542 doi:10.1136/bmkj.b1542

Psoriasis and sensitive areas
Last review: July 2015
Published: January 2016
Next review: March 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL,Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A populationbased study. Arch Dermatol 2005; 141:1537-41.
  • Smith CH et al., Psoriasis and its management. British Medical Journal. 2006; 333-380.
  • Rook’s textbook of dermatology, eighth edition. Eds: T Burns, S Breathnach, N Cox & C Griffiths. Wiley- Blackwell, Oxford.
  • The assessment and management of psoriasis. National Institute for Health and Clinical Excellence. NICE clinical guideline 153. October 2012.

Psoriasis and the Heart
Last review: August 2015
Published: December 2015
Next review: July 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin
  • JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005; 141: 1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999; 26:1752-6.
  • Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
  • Martyn-Simmons CL, Ranawaka RR, Chowienczyk P, Crook MA, Marber MS, Smith CH, Barker JN. A prospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis. Br J Dermatol 2011; 164: 26-32.
  • Kessler R. Under their skin. Nature 2012; 492: S64-5. www.diabetes.co.uk
  • Parisi R, Rutter MK, Lunt M, Young HS, Symmons DP, Griffiths CEM, Ashcroft DM; Identification and Management of Psoriasis Associated ComorbidiTy (IMPACT) project team. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research database. J Invest Dermatol 2015; 135: 2189-97.

Psoriasis and the Sun
Last review: August 2015
Published: January 2016
Next review: January 2016

References:


Psoriatic Arthritis: Did You Know?
Last review: February 2016
Published: March 2016
Next review: December 2018

References:

  • Kay LJ, Parry-James JE, Walker DJ. The prevalence and impact of psoriasis and psoriatic arthritis in the primary care population in North East England. Arthritis Rheum 1999;42:S299.
  • Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis - an analysis of 220 patients. Q J Med 1987;62:127.
  • McHugh NJ, Balakrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis. Rheumatology 2003;42:778.
  • Pedersen OB, Svendsen AJ, Ejstrup L, et al. On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins. Ann Rheum Dis 2008;67:1417.
  • Turkiewicz, AM, Moreland, LW. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 2007;56:1051.
  • Cassell, SE, Bieber, JD, Rich, P, et al. The modified nail psoriasis severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007; 34:123.
  • McGonagle D, Lories RJU, Tan AL, et al. The concept of a “synovio-entheseal complex” and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis & Rheumatism 2007;56:2482.

Psoriatic arthritis: When to treat
Last review: June 2016
Published: June 2016
Next review: January 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA and Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005; 141: 1537-41
  • Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009; 68: 1387-94.
  • Gladman DD, Antoni C, Mease P, Clegg DO and Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005; 64 Suppl 2: ii14-7.
  • Ash Z, Gaujoux-Viala C, Gossec L, et al. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis. 2011.
  • Gossec L, Smolen JS, Gaujoux-Viala C, et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2011; 71: 4-12.
  • Kyle S, Chandler D, Griffiths CE, et al. Guideline for anti- TNF-alpha therapy in psoriatic arthritis. Rheumatology (Oxford). 2005; 44: 390-7.
  • Zangger P, Gladman DD, Urowitz MB and Bogoch ER. Outcome of total hip replacement for avascular necrosis in systemic lupus erythematosus. J Rheumatol. 2000; 27: 919-3.
  • Ng SC and Chan FK. NSAID-induced gastrointestinal and cardiovascular injury. Current opinion in gastroenterology. 2010; 26: 611-7.

Psoriatic Lifestyle and Nutrition

Published: May 2017
Next review: November 2020

  • [Parisi, R, Symmons, DPM, Griffiths, CEM & Ashcroft, DM 2013, 'Global epidemiology of psoriasis: A systematic review of incidence and prevalence' Journal of Investigative Dermatology, vol 133, no. 2, pp. 377-385., 10.1038/jid.2012.339]
  • [Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.]
  • [Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.]
  • [The assessment and management of psoriasis. National Institute for Health and Care Excellence (NICE). NICE clinical guideline 153. October 2012]
  • [Sign guideline 121:Diagnosis and management of psoriasis and psoriatic arthritis in adults October 2010]
  • Mancini JG, Filion KB, Atallah R, Eisenberg MJ.  Systematic  Review of the Mediterranean Diet for Long-Term Weight Loss.  Am J Med. 2016; 129:407-415
  • Barrea L, Nappi F, Di Somma C, et al.   Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist Int. J. Environ. Res. Public Health 2016; 13, 743
  • Millsop JW, Bhatia BK, Debbaneh M, et al.  Diet and Psoriasis: Part 3.  Role of Nutritional Supplements.   J Am Acad Dermatol. 2014; 71: 561–569
  • Behnam, S., et al. Alcohol as a risk factor for plaque-type psoriasis. Cutis 2005,76; 181-185
  • Behnam, S. et al. Smoking and psoriasis. SKINMed 2005 ;4:174-176.

Psychological aspects of psoriasis
Last review: April 2015
Published: May 2015
Next review: March 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • O’Leary, Creamer, Higgins, Weinman, 2004; Perceived stress, stress attributions and psychological distress in psoriasis. Journal of Psychosomatic Research, 57(5), 465-471.

Pustular psoriasis
Last review: November 2014
Published: December 2014
Next review: October 2016

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: A systematic review. J Rheumatol 2008;35:1354-8.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.
  • Reitamo S, Erkko P, Remitz A. Palmoplantar pustulosis. Eur J Dermat 1992; 2: 311-4
  • Barker H. Pustular psoriasis. Dermat Clin 1984; 2: 455.
  • Rook’s Textbook of Dermatology, Eighth Edition. Eds:  Burns T, Breathnach S, Cox N, Griffiths C. Wiley-Blackwell, Oxford.
  • Hagforsen E, Michalsson G. Palmoplantar Pustulosis – Improvement after cessation of smoking. Abstract Number 391. 34th Annual ESDE Meeting. 9 – 11 September 2004, Vienna. Austria.
  • O’Doherty C J, Macintyre C. Palmoplantar pustulosis and smoking. British Medical Journal Volume 291 28 September 1985.

Scalp Psoriasis
Last review: August 2015.
Published: October 2015
Next review: March 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • NICE http://publications.nice.org.uk/psoriasisifp153/ initial-treatment-with-topical-medication
  • www.haircouncil.org.uk

The Psoriatic Foot
Last review: April 2016
Published: May 2016
Next review: November 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008;35:1354-8. 10 Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.
  • Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PsA) - an analysis of 220 patients. Q J Med 1987;62:127-41.
  • Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64 Suppl 2:ii14-7.
  • Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol
  • Alamino RP, Maldonado Cocco JA, Citera G, et al. Differential features between primary Ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol
  • McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford) 2003;42: 778-83.
  • Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387-94.
  • Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573.

Treatments for Psoriasis: An overview
Last review: July 2014
Published: August 2014
Next review: August 2014

References:

  • Gelfand JM,  Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005;141:1537-41.
  • British National Formulary 2012 March No 63 BMJ & Pharmaceutical Press
  • The assessment and management of psoriasis. National Institute for Health and Clinical Excellence. NICE clinical guideline 153. October 2012
  • Burfield L, Burden AD. Psoriasis Physicians Edinb. 2013 J R Coll;43(4):334-8; quiz 339. doi: 10.4997/JRCPE.2013.414.
  • Sign guideline 121:Diagnosis and management of psoriasis and psoriatic arthritis in adults October 2010
  • The assessment and management of psoriasis. National Institute for Health and Clinical Excellence. NICE clinical guideline 153. October 2012.
  • British National Formulary  March- September 2016 No 71 BMJ & Pharmaceutical Press
  • Monthly Index of Medical Specialities June 2016 Haymarket

Treatment for Psoriatic Arthritis: An overview
Last review: April 2015
Published: May 2015
Next review: May 2015

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005; 141:1537-41.
  • Cassell, SE, Bieber, JD, Rich, P et al. The modified nail psoriasis severity index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007; 34:123.
  • Thor a x 2005; 60:800-805. Doi : 10.1136/ thx.2005.046797
  • Chakravarty K, McDonald H, Pullar T et al. BSR/BHPR guideline for disease-modifying antirheumatic drug (DMARD) therapy in consultation with the British Associat ion of Dermatologists. Doi :10.1093/ rheumatology/ke1216b
  • There is a large body of evidence for the benefits of exercise in inflammatory arthritis. It has usually been studied using rheumatoid arthritis (RA).
  • NICE guidelines 2009 state that exercise is beneficial for most individuals with RA.
  • Evidence for exact prescription, modes of exercise delivery and improving compliance with an exercise programme are limited. The current knowledge is summarised in:
  • Cooney JK et al. Benefits of exercise in RA. Journal of aging research 2011; 1-14 (article ID 681640).
  • Hakkinen A et al. A randomised two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 2001; 44:515.

What is Psoriasis?
Last review: March 2016
Published: May 2016
Next review: April 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: A population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: A systematic review. J Rheumatol 2008;35:1354-8.
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.
  • Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377-85.

What is Psoriatic Arthritis?
Last review: February 2016
Published: March 2016
Next review: March 2018

References:

  • Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005;141:1537-41.
  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.
  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008;35:1354-8. 10
  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
  • Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.
  • Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PsA) - an analysis of 220 patients. Q J Med 1987;62:127-41.
  • Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64 Suppl 2:ii14-7.
  • Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol
  • Alamino RP, Maldonado Cocco JA, Citera G, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol
  • McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study. Rheumatology (Oxford) 2003;42:778-83.
  • Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387-94.
  • Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573.
  • http://www.nhs.uk/Change4Life [accessed February 2016]
  • N Engl J Med 2009;361:496-509
  • Office for National Statistics – Adult internet usage 2015 http://www.ons.gov.uk/ons/dcp171778_404497.pdf [accessed February 2016] 

Below is a list of information citations or sources which have been used to reference the site content 


  • Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: A tale of two subgroups. Curr Opin Rheumatol 2011; 23(5) 437-43

  • Alamino RP, Maldonado Cocco JA, Citera G, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 2011; 38(8) 1656-60

  • Scottish Intercollegiate Guidelines Network (SIGN). Diagnosis and management of psoriasis and psoriatic arthritis in adults. Edinburgh: SIGN; 2010. (SIGN publication no. 121). - cited 12 Oct 2010.
  • Available from: www. sign .ac.uk

  • Wandel S, Juni P...et al Effects of glucosamine, choddroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis BMJ 2010;341:c4675 doi:10.1136/bmj.c4675

  • Best Practice 2010 Psoriatic arthritis, History and Examination (online) available http: //bestpractice.bmj.com/best-practice/monograph/524/diagnosis.html (accessed September 2010)

  • Best Practice 2010 Psoriatic arthritis, Complications (online) http: //bestpractice.bmj.com/best-practice/monograph/524/follow-up/complications.html available (accessed September 2010)

  • Griffiths CEM, Strober BE ... et al, Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis NEJM 2010 Number 2; Vol 362:118-128

  • Boehncke W, Boehncke S, Schon M Managing comorbid disease in patients with psoriasis British Medical Journal: 2010: 340: b56666

  • Ritchlin CT, Kavanaugh A, Gladman DD, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387-94.

  • Koek M, Buskins E, van Weelden H, Steegmans P, Bruijnzeel-Koomen C, Sigurdsson V. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis; pragmatic multicentre randomized controlled non-inferiority trial (PLUTO study) British Medical Journal 2009:338:b1542 doi:10.1136/bmkj.b1542

  • Ameen M, Etemesi B, Managing Psoriasis in the Tropics: Community Dermatology 2009: 9 5-7

  • Anstey Alex, professor. Home UVB phototherapy for psoriasis :Editorials BMJ 2009;338:b607

  • Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Care & Research 2009; 61(10):1373-1378.

  • Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Archives of Dermatology 2009;145:379-82.

  • Costing statement: Ustekinumab for the treatment of adults with moderate to severe psoriasis (2009) NICE technology appraisal guidance 180 (TA180) Available from: www. nice .org.uk/TA180

  • Duffy KC; Abstract and oral presentation at Society for Investigative Dermatology Meeting (SID), Montreal, Canada 2009

  • Radtke M, Reich K, Blome C, et al. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Academy of Dermatology Venereol. 2009 Mar 4. (Epub ahead of print)

  • Pietrzak A, Kadzielewski J, Janowski K et al. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. International Journal of Dermatol 2009;48:379-87.

  • Psoriasis and the Risk of Diabetes and Hypertension: A Prospective Study of US Female Nurses Archives of Dermatology .2009;145 (4):379-382.

  • Food standards agency 2009 Folic acid fortification (online) Available http:// www. food. gov.uk/healthiereating/folicfortification / (accessed November 2009)

  • British Nutrition Foundation 2009 Healthy varied diet (online) Available http:// www. nutrition.org.uk (accessed November 2009)

  • Eczema, pruritus, dry skin conditions, Emollients: 380 – 384: MIMS October 2009

  • Psoriatic Arthritis The Facts Gladman D, Chandran V: Patterns of psoriatic arthritis: 2009: 7-8. Oxford University Press.

  • Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: A systematic review. J Rheumatol 2008;35:1354-8.

  • Estimated prevalence of psoriasis obtained from costing template and report for adalimumab for the treatment of adults with psoriasis (2008). NICE technology appraisal guidance 146 (TA146). Available from: www. nice .org.uk/TA146

  • Chen YJ, Wu CY, Shen JL et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Archives of Dermatology 2008;144:1571-1575

  • Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. British Journal of Dermatology 2008; 159:895-902

  • Gisondi P, Del Giglio M, Di Francesco V et al. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. American Journal of Clinical Nutrition 2008; 88:1242-7.

  • Lapsley P Referral management schemes are damaging patients' interests British Medical Journal 2007 334: 156

  • Setty A R, Curhan G, Choi H K Smoking and the Risk of Psoriasis in Women Nurses Health Study II: The American Journal of Medicine, Volume 120: 11 (November 2007).

  • Menter A, Griffiths C, Current and future management of psoriasis The Lancet: 370: 272 – 284, July 2007

  • Griffiths C, Pathogenesis and clinical features of psoriasis The Lancet : 370: 263 - 271, 21 July 2007

  • Ravelli A, Martini A Juvenile Idiopathic Arthritis The Lancet: 369: 9563: 767 - 778, 3 March 2007

  • Weatherhead S, Robson S, Reynolds J Pregnancy Plus: Management of psoriasis in pregnancy BMJ 2007. 334. Pages 1218-1220

  • Mitchell T, Penzer R Psoriasis at your fingertips A family connection?: 4 – 7 2007 - Class Publishing, London.

  • Weatherhead S, Robson S, Reynolds J Pregnancy Plus: Management of psoriasis in pregnancy British Medical Journal 2007: 334: 1218-1220

  • Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Annals of Rheumatic Disease. 2008 May;67(5):672-6. Epub 2007 Sep 6._

  • Griffiths C, Barker J. Pathogenesis and clinical features of psoriasis. The Lancet: 370: 9583: 263 - 271, 21 July 2007

  • Huerta C, Rivero E, Rodríguez LA. Incidence and risk factors for psoriasis in the general population. Archives of Dermatology 2007; 143: 1559-1565. CrossRef | PubMed

  • Estimated proportion of people with severe psoriasis eligible for biological therapy obtained from costing templates and reports for TA103 and TA146. (2006) Available from: www. nice .org.uk/TA103 and www. nice .org.uk/TA146

  • Smith CH, Barker JNWN Psoriasis and its management British Medical Journal: 2006 333:380-384 (19 August)

  • Smith CH, Barker J, Psoriasis and its management British Medical Journal: 2006 333:380-384 19 August 2006

  • de Menezes Ettinger JE, Azaro E, de Souza CA et al. Remission of psoriasis after open gastric bypass. Obes Surg 2006; 16:94-7

  • Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the united states. J Am Acad Dermatol 2005;53:573.

  • Krueger JG, Bowcock A. Psoriasis pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-6.

  • Camapalani E, Barker J The Clinical Genetics of Psoriasis Current Genomics: 2005: 6: 51-60

  • Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Annals of Rheumatic Disease. 2005;64(Suppl 11):ii 14- ii17

  • Gelfand JM, Weinstein R, Porter SB et al Prevalence and Treatment of Psoriasis in the United Kingdom: A Population-Based Study Archives of Dermatology. 2005; 141:1537-1541.

  • Warin A Understanding Psoriasis, Common forms of psoriasis: Pages 16 – 17. 2005. Family Doctor series - The British Medical Association

  • Herron MD, Hinckley M, Hoffman MS et al. Impact of Obesity and Smoking on Psoriasis Presentation and Management. Archives of Dermatology. 2005;141:1527-1534.

  • Higa-Sansone G, Szomstein S, Soto F et al. Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obesity Surgery 2004; 14:1132-4.

  • Madison, Isenberg, Woo & Glass, Oxford Textbook of Rheumatology 2004 page 751

  • McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study. Rheumatology (Oxford) 2003;42:778-83.

  • Lebwohl M, Psoriasis The Lancet : 361: 1197 - 204, 5 April 2003

  • Jones W When ignorance is not bliss British Medical Journal: 2003: 327:877

  • Fortune, D.G., Richards, H.L., Kirby, B., McElhone, K., Markham, T., Rogers, S., Main, C.J. & Griffiths, C.E.M. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Archives of Dermatology, 139, 752-756.

  • Richards, H.L., Fortune, D.G., Griffiths, C.E.M., Main, C.J. (2001). The contribution of perceptions of stigmatisation to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11-15.

  • Fortune, D.G., Richards, H.L., Main, C.J. & Griffiths, C.E.M. (2000). Pathological worrying, illness perceptions and disease severity in patients with psoriasis. British Journal of Health Psychology, 5, 71-82.

  • Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: Analysis of 221 patients with active psoriatic arthritis.Department of veterans affairs cooperative study group on seronegative spondyloarthropathies. J Rheumatol 1999;26:1752-6.

  • Naldi, Peli L, Parazzini F (1999) Association of early stage psoriasis with smoking and male alcohol consumption Archives of Dermatology. 1999:135:1479-1484

  • Fortune, D.G., Richards, H.L., Main, C.J. & Griffiths, C.E.M. (1998). What patients with psoriasis believe about their condition. Journal of the American Academy of Dermatology, 137, 53-59.

  • Stern R, Psoriasis The Lancet : 350: 349 - 53, 2 August 1997

  • Fortune, D.G., Main, C.J., O'Sullivan, T.M. & Griffiths C.E.M. (1997). Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. British Journal of Dermatology, 137, 755-760.

  • Naldi L, Parazzin F, Peli L, Chatenoud L, Cainelli T Dietary factors and the risk of psoriasis British Journal of Dermatology 1996 Jan: 134 (1) 101-6

  • Williams HC Smoking and Psoriasis BMJ 1994;308:428-429

  • Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (psa)--an analysis of 220 patients. Q J Med 1987;62:127-41.

  • Jowett, S. & Ryan, T. (1985). Dermatology patients and their doctors. Clinical and Experimental Dermatology, 10, 246-254.

  • Jowett S, Ryan T. 1985. Skin Diseases and handicap: An analysis of the impact of skin conditions. Social Science Medicine 20: 425-9

  • Rogers R, Watt I, Dieppe P Arthritis in Saxon and Mediaeval skeletons British Medical Journal 1981: 283: 19 - 26 December: 1668 - 1669

  • Amyloidosis complicating psoriatic arthritis British Medical Journal 1977: 30 July: 302

  • Psoriatic arthritis: to lump or to split? British Medical Journal 1976: 28 August: 491

  • Napkin Psoriasis British Medical Journal 1971: 21 August: 443 - 444

    Historic background archive


  • Feldman S, Advances in Psoriasis Treatment. Dermatology Online Journal 2004 Volume 6, Number 1

  • Psoriatic Arthritis News and Views Psoriatic Arthritis Medical News Vol 3 Issue 14 - August 15 2003

  • Fladman D Psoriatic arthritis (online www. smartpatient.net accessed June 2001)Psoriasis Resource: An active approach to helping arthritis National psoriasis Foundation Volume 1, Number 2, July 1999

  • Van Der Vleuten C, De Jong E, Rulo E, Gerritsen M and Kerkhof P. In patient treatment with calcipotriol versus dithranol in refractory psoriasis Clinical report. Eur J Dermatol 1995, 5:676-9

  • Wright V, Helliwell P Psoriatic Arthritis Topical Reviews May 1992 No 21

  • Moll J Psoriatic Spondylitis:Clinical Radiological and Familial Aspects Proc. roy Soc Med Volume 67 January 1974

  • Baker H, Golding D, Thompson M Psoriasis and Arthritis Annals of Internal Medicine Volume 58, June 1963 No 6

  • Finlay A, Corvest M, Smadja C, Lefrancois P, Myon E, Taieb Ch Psoriasis and Current Life: Preliminary Results on 527 Subjects Programmes Pharmaco-Economiques

  • Psoriatic Arthritis Rheumatic Disease in the Adult Child Chapter 7

    Resources | About Psoriasis | Psoriasis Treatments | About Psoriatic Arthritis | Psoriatic ArthritisTreatments | Articles | Further informationImage Gallery | Downloads | A-Z encyclopaedia | Other Diseases | Skin ‘n’ Bones Connection | References | Misspell | FAQs